FDA Approves Optimer’s DIFICID (fidaxomicin) Tablets for the Treatment of Patients with Clostridium difficile …
Optimer Pharmaceuticals, Inc. announced today that the U.S. Food and Drug Administration has approved the company’s antibacterial drug DIFICID⢠tablets for the treatment of Clostridium difficile-associated diarrhea in adults 18 years of age and older.
Alien – Extended Chestburster

